Skip to main content
All blogsClinical

Lab Work Before Starting Peptides

The honest answer to "what bloodwork do I need before peptides?" is: it depends on the peptide, and for many of them the answer is none. Some sites will tell you to buy a full baseline panel before anything, because they sell the panel. Here is the real picture, which peptides typically need no labs, where a provider may want to check IGF-1 and a metabolic panel, and why the decision belongs to the provider reviewing your history rather than to a checklist.

PeRx PeptidesReviewed by Dr. Cory Mellon, MD11 min readPublished
The honest answer to "what bloodwork do I need before peptides?" is: it depends on the peptide, and for many of them the answer is none.
The honest answer to "what bloodwork do I need before peptides?" is: it depends on the peptide, and for many of them the answer is none.

Key Takeaways

  • For many peptides, no lab work is required to start. BPC-157, TB-500, and GHK-Cu are common examples that typically need no bloodwork.
  • Growth-hormone peptides (Sermorelin, CJC-1295/Ipamorelin, Tesamorelin) are the category where a provider is most likely to consider a baseline IGF-1 and a basic metabolic panel, because these peptides raise IGF-1.
  • The provider reviewing your intake decides whether labs are useful, based on the peptide requested and your health history. It is a clinical judgment, not a fixed rule.
  • PeRx starts with a roughly five-minute online assessment that a licensed provider reviews. No labs are required to complete it.
  • Some patients get a baseline panel for their own peace of mind. That is a reasonable choice, not a prerequisite for most peptides.

Lab work before peptides, at a glance

Required to start?

For many peptides, no. It depends on the peptide and your history.

Usually no labs

BPC-157, TB-500, GHK-Cu and similar healing or cosmetic peptides

Labs more likely

Growth-hormone peptides: Sermorelin, CJC-1295/Ipamorelin, Tesamorelin

Most common test

IGF-1, sometimes with a basic metabolic panel

Who decides

The licensed provider reviewing your intake, not a fixed checklist

PeRx assessment

About 5 minutes online. No labs required to complete it.

The Honest Answer

It depends on the peptide, and often the answer is none

If you search "what bloodwork do I need before peptides," you will find a lot of pages telling you to buy a full baseline panel before anything. Many of those pages sell the panel. The straight answer is narrower and more useful: for a large share of commonly requested peptides, no labs are required to start. Growth-hormone peptides are the category where a provider is more likely to want a baseline. The decision belongs to the licensed provider reviewing your history, not to a one-size checklist.

Peptides are not a single thing, so "do I need labs" does not have a single answer. A peptide used for tissue repair and a peptide that nudges your growth-hormone axis are doing different work in the body, and they carry different reasons to look at bloodwork. Grouping them all under one lab requirement is what leads people to either over-test out of anxiety or assume no one is paying attention. The accurate version sits in between.

This guide is about what a provider may review, not a list of hoops you must clear. That framing matters. At PeRx the process begins with a short online health assessment, and a licensed provider reads it before anything is prescribed. If your history or the specific peptide makes labs useful, the provider asks. If it does not, you are not sent to a lab draw to justify a purchase. For the fuller picture of what a provider looks at, see what providers review before prescribing peptides.

Peptides That Usually Need No Labs

The peptides people ask about most often for recovery, joints, gut, skin, and connective tissue generally do not require bloodwork to begin. These are working locally on repair and signaling rather than reshaping a hormone axis, so there is usually no lab value a provider needs to see before a first cycle in an otherwise healthy adult.

BPC-157

Typical use
Tissue and gut repair, recovery
Labs usually needed to start?
No, in most healthy adults. History review is what matters.

TB-500 (in the BPC/TB-500 combo)

Typical use
Recovery and connective-tissue support
Labs usually needed to start?
No, in most healthy adults.

GHK-Cu

Typical use
Skin, hair, and cosmetic support
Labs usually needed to start?
No. Commonly requested with no bloodwork to begin.

Selank, Semax

Typical use
Calm focus and cognitive support
Labs usually needed to start?
No labs to start for most adults.

What still matters for these peptides is the history review, not a blood draw. A provider still wants to know your medications, allergies, any cancer history, and whether you are pregnant or breastfeeding. Those questions live in the intake, and they do their work whether or not a lab is ever ordered. If you want the mechanics of how peptides fit into a prescribed model at all, what is peptide therapy is the primer.

Where Labs Come In: Growth-Hormone Peptides

The growth-hormone secretagogues are the clearest case where a provider may want a lab. These peptides work by prompting your pituitary to release more of your own growth hormone, which in turn raises IGF-1, the downstream marker that reflects growth-hormone activity. Because the whole point is to move that axis, a baseline reading is more meaningful here than it is for a repair peptide.

Sermorelin

What it does
Prompts natural growth-hormone release
Lab a provider may consider
Baseline IGF-1; sometimes fasting glucose or a metabolic panel

CJC-1295 with Ipamorelin

What it does
Paired secretagogues for a steadier GH signal
Lab a provider may consider
Baseline IGF-1; a basic metabolic panel in some cases

Tesamorelin

What it does
GH-releasing peptide studied for visceral fat
Lab a provider may consider
IGF-1; a provider may review glucose given metabolic effects

Why IGF-1, specifically

IGF-1 is the practical yardstick for growth-hormone activity. A baseline gives a provider a reference point and helps confirm the therapy makes sense for you rather than being a shot in the dark. Research on growth-hormone secretagogues in men documented meaningful increases in serum IGF-1 with treatment, and IGF-1 is the marker the Endocrine Society leans on in growth-hormone care. That is context for why a provider might want the number, not a promise that you personally will be asked for it.

Sigalos JT, et al. "Growth Hormone Secretagogue Treatment in Hypogonadal Men Raises Serum Insulin-Like Growth Factor-1 Levels." American Journal of Men's Health, 2017. Documents that GH secretagogue treatment measurably raised serum IGF-1, which is the basis for using IGF-1 as a reference marker. View study

Molitch ME, et al. "Evaluation and Treatment of Adult Growth Hormone Deficiency: An Endocrine Society Clinical Practice Guideline." Journal of Clinical Endocrinology & Metabolism, 2011. Establishes IGF-1 as a core marker in the clinical evaluation and monitoring of growth-hormone status in adults. View study

Two honest caveats. First, most published IGF-1 monitoring guidance comes from the endocrinology world of diagnosed growth-hormone deficiency and formal replacement, which is a stricter context than optimization-focused peptide use, so a provider applies judgment rather than copying a protocol. Second, whether a baseline is ordered still depends on you: your age, your history, and what you are trying to accomplish. The peptide category raises the odds a lab is useful. It does not turn a lab into an automatic requirement.

The Labs a Provider May Review

When labs are useful, the list is short and ordinary. None of this is exotic. It is the same everyday bloodwork a primary-care visit might involve, chosen for the reason it applies to your situation rather than ordered wholesale to build a bill.

IGF-1

What it reflects
Growth-hormone activity
When a provider might want it
Most relevant for growth-hormone peptides, as a baseline reference.

Basic or comprehensive metabolic panel

What it reflects
Kidney and liver function, glucose, electrolytes
When a provider might want it
Sometimes alongside GH peptides, or when history suggests it.

Fasting glucose or HbA1c

What it reflects
Blood-sugar regulation
When a provider might want it
When there is existing insulin resistance or diabetes to account for.

Complete blood count

What it reflects
Red and white cells, platelets
When a provider might want it
As part of a general baseline, if a provider wants a fuller picture.

Be wary of "everyone needs a full panel first"

A blanket rule that every patient must buy a comprehensive panel before any peptide is usually a sign the seller profits from the panel. The clinically honest position is that testing should have a reason. For a repair peptide in a healthy adult there is often no lab that changes the plan. For a growth-hormone peptide there frequently is. Matching the test to the situation is exactly the judgment a provider is there to make.

Baseline Labs for Peace of Mind

Separate from anything a provider requires, some patients simply like to start with a baseline. There is nothing wrong with that. A general panel, such as a CBC, a comprehensive metabolic panel, and IGF-1, gives you a personal reference point and can surface things worth knowing whether or not peptides are involved. If you are the kind of person who wants numbers before and after, getting a baseline is a reasonable choice you can make on your own.

Two practical notes. If you already have recent labs from a physical, sharing them with your provider during the review is genuinely helpful and may mean nothing new is needed. And if you choose to test, fasting matters for glucose and lipid values, so an early-morning draw after an overnight fast gives cleaner numbers. Beyond that, a baseline is optional. It is a want-to, not a have-to, for most peptides. Ongoing tracking, if you pursue therapy, is covered in peptide safety monitoring.

How PeRx Handles Labs

The PeRx model is built so that testing is driven by clinical need, not by policy. You are not sent to a lab draw to unlock a checkout. You complete a short assessment, a licensed provider reads it, and if labs would make the prescribing decision better, the provider asks for them before prescribing. That is the whole logic: informed prescribing, without friction that does not earn its place.

What the process actually looks like

Step 1

You complete a roughly five-minute online health assessment covering goals, history, current medications, and allergies. No labs are required to complete it, and there is no in-person visit.

Step 2

A licensed provider reviews your intake. For many peptides that review is all that is needed. For growth-hormone peptides, or if your history calls for it, the provider may ask for a baseline lab such as IGF-1.

Step 3

If appropriate, the provider prescribes your protocol and it is compounded at a US-based 503A pharmacy. Vials ship fully reconstituted and ready to use, refrigerated, with nothing to mix on your end.

Step 4

You manage routine dosing. The provider prescribes the protocol; they do not coach or adjust day to day. A brief renewal check-in at the end of each prescription cycle opens the next window.

The upshot for the common question is simple. For many peptides, you can start without bloodwork. For growth-hormone peptides, a baseline lab may be part of the picture, at the provider's discretion. Either way, the person deciding is a named, credentialed provider reviewing your actual history, which you can read more about on our team page. If you want to see what fits your goals, the assessment is the fastest way, and you can browse the full catalog of peptides first if you prefer.

Lab Work Before Starting Peptides: Common Questions

Often not. It depends on the peptide and your history. Many commonly requested peptides such as BPC-157 and GHK-Cu typically need no labs to begin. Growth-hormone peptides like Sermorelin, CJC-1295 with Ipamorelin, and Tesamorelin are where a provider is more likely to consider a baseline IGF-1 and a metabolic panel. The provider reviewing your intake decides. At PeRx no labs are required to complete the short online assessment.

As a general pattern, healing and cosmetic peptides such as BPC-157, TB-500, and GHK-Cu usually need no bloodwork to start, while growth-hormone secretagogues (Sermorelin, CJC-1295/Ipamorelin, Tesamorelin) are the category where a provider may want a baseline IGF-1 and a metabolic panel. This is a tendency, not a strict rule, and the provider reviewing your history makes the final call.

Growth-hormone secretagogues prompt your body to release more growth hormone, which raises IGF-1. A baseline IGF-1 gives a provider a reference point and helps confirm the therapy makes sense for you. Research on GH secretagogues in men documented measurable rises in serum IGF-1, and the Endocrine Society uses IGF-1 as a core marker in growth-hormone care. Whether it is ordered for you is a clinical judgment made at intake.

No. The process starts with a short online health assessment that takes about five minutes and covers goals, history, current medications, and allergies. A licensed provider reviews it, and no labs are required to complete it. If your history or the peptide you requested makes labs useful, the provider will ask for them before prescribing rather than after.

Some patients like to, and it is a reasonable choice. A baseline panel such as a CBC, a comprehensive metabolic panel, and IGF-1 gives you a personal reference point and can surface things worth knowing regardless of peptides. It is optional, not a requirement, for most peptides. If you already have recent labs, sharing them with your provider during the review is helpful.

Not as a blanket rule. Testing should have a clinical reason. For a repair peptide in a healthy adult, there is often no lab that would change the plan, so a mandatory full panel usually reflects a seller who profits from the panel more than a medical necessity. For a growth-hormone peptide, a baseline lab is more likely to be genuinely useful. A provider matching the test to your situation is the honest version.

In most healthy adults, no. These are among the peptides commonly requested with no bloodwork to begin. What still matters is the history review: your medications, allergies, any cancer history, and pregnancy or breastfeeding status. Those questions live in the intake and do their work whether or not a lab is ever ordered.

If the reviewing provider decides a lab would improve the prescribing decision, they ask for it before prescribing rather than after. That keeps the decision informed without turning a blood draw into a checkout requirement for peptides that do not need one. If you already have recent, relevant labs, sharing them can mean nothing new is needed.

For glucose and lipid values, yes. An early-morning blood draw after an overnight fast of eight to twelve hours, water only, gives cleaner numbers for those markers. IGF-1 itself is less sensitive to fasting, but if a metabolic panel is part of the draw, fasting is worth planning around.

Related Guides

Continue reading about peptides and protocols that pair well with this guide.

Ready to get started?

Take our short health assessment. A licensed provider reviews every intake and decides whether any lab work is useful based on the peptide and your history. For many peptides, none is needed to start. Pharmaceutical-grade peptides, prescribed and compounded at a US-based 503A pharmacy, shipped ready to use.

Medical Disclaimer

The information provided on this website, including all articles, guides, and educational content, is for informational and educational purposes only and is not intended as medical advice, diagnosis, or treatment. Nothing on this site should be construed as a substitute for professional medical advice from a qualified healthcare provider.

The majority of peptides discussed on this site are not approved by the U.S. Food and Drug Administration (FDA) for the indications described. They are classified as bulk drug substances and are available only through a licensed prescribing provider and compounding pharmacy. All treatments require a valid prescription and provider oversight.

The majority of published research on peptide therapies has been conducted in preclinical (animal) models. While early human data is encouraging, comprehensive clinical trial data remains limited for most peptide compounds. Individual results may vary significantly based on health status, injury type, and other factors. No specific outcomes are guaranteed.

Certain peptides discussed on this site are classified as prohibited substances by the World Anti-Doping Agency (WADA) and are banned by major sports organizations including the NFL, NCAA, UFC, NBA, MLB, NHL, and PGA. If you are subject to anti-doping testing, consult your governing body before considering any peptide therapy.

Statements on this website have not been evaluated by the Food and Drug Administration. Products and therapies discussed are not intended to diagnose, treat, cure, or prevent any disease.

© 2026 Wellness MD Group PC DBA PeRx. All rights reserved.